MedPharm's R&D facilities

Company Profile

MedPharm Ltd is an innovation-driven pharmaceutical development company committed to the identification, creation and development of unique therapeutic systems for topical use specialising in drug delivery to the skin, nail, mucous membranes, eye, nose and lung.

MedPharm offers a unique and highly specialised service in the area of pharmaceutical contract research and development. Capabilities comprise analytical, preformulation, formulation, in-vitro performance testing, GMP manufacture and preclinical and clinical evaluation. 

 The MedPharm team combines years of commercial experience in the pharmaceutical industry with the benefit of high-calibre scientists . MedPharm now has over 50  employees with in excess of 45 in R&D.

MedPharm has a range of partners from large pharmaceutical to small biotechnology companies who require tailored solutions during the development of their products.
Additionally, MedPharm is actively developing it's own proprietary drug delivery technologies in the topical and pulmonary fields which can be made available to third parties on a 'Licensing and Technology Transfer' basis.

MedPharm's expertise includes:

  • Contract formulation development
  • Development and application of novel in-vitro models for drug candidate selection, formulation optimisation and efficacy testing
  • Development and licensing of proprietary drug delivery technologies

MedPharm operates to exacting standards using world-class resources:

  • Highly skilled and experienced R&D personnel with formulation and analytical backgrounds enjoying high credibility within the industry
  • Scientific advisory board comprising renowned pharmaceutical experts
  • Proven documentation, quality systems and project management
  • "Smart systems" for formulation development
  • GLP testing facilities
  • GMP facilities for clinical supplies
  • Capability to generate new intellectual property
  • State-of-the-art laboratory facilities and equipment
  • Preclinical and clinical expertise
  • Knowledge of worldwide regulatory requirements

History

MedPharm was created in 1999 as a spin-out of King's College London by Prof. Chris Marriott, Prof. Gary Martin and Prof. Marc Brown, all from the Department of Pharmacy, and also Dr. Andrew Muddle, who joined the company at formation as Chief Executive.

MedPharms R&D laboratories were originally based at Kings College London but MedPharm has grown at such a pace that aquiring our own dedicated R&D facilities became essential. In autumn 2006 the Pharm R&D Centre was relocated to Surrey Research Park, Guildford allowing significant expansion of R&D activities.

Return to topReturn to top

Facilities

MedPharm's R&D Centre and main laboratory facilities are located in Surrey Research Park, Guildford. Refurbishment of the new laboratories at Surrey Research Park has provided MedPharm with an excellent base to service both our current and future growth plans and is convieniently located being close to London and its major airports.

MedPharm's laboratories are GLP accredited.

MedPharm has its BioLab linked to the University of Hertfordshire for Class II biological hazard studies

MedPharm also has access to a GMP facility which is based close to London. 

Return to topReturn to top

Company Presentation

This document is a general overview of MedPharm. It may be used as a visual aid during introductory teleconferences with MedPharm's business development team.

MedPharm Corporate(PDF)